cancer of other female genital organs	is a	cancer
cancer of other female genital organs	is malignant	malignancy
bartholin gland cancer	is a type of	cancer of other female genital organs
vaginal cancer	is a type of	cancer of other female genital organs
vulvar cancer	is a type of	cancer of other female genital organs
cancer of other female genital organs	presents with	vaginal bleeding
cancer of other female genital organs	presents with	pelvic pain
cancer of other female genital organs	presents with	mass lesion
cancer of other female genital organs	metastasizes to	inguinal lymph nodes
cancer of other female genital organs	metastasizes to	liver
cancer of other female genital organs	metastasizes to	lungs
cancer of other female genital organs	metastasizes to	bone
cancer of other female genital organs	metastasizes to	brain
lymph node involvement	indicates	advanced cancer of other female genital organs
lymphovascular invasion	indicates	aggressive cancer of other female genital organs
FIGO staging	used for	cancer of other female genital organs
MRI	used for	local staging of cancer of other female genital organs
CT scan	used for	distant metastasis detection in cancer of other female genital organs
PET-CT	used for	metastatic workup of cancer of other female genital organs
biopsy	confirms	cancer of other female genital organs
histology	reveals	squamous cell carcinoma
histology	reveals	adenocarcinoma
histology	reveals	melanoma
surgical resection	for	early-stage cancer of other female genital organs
radical surgery	for	advanced cancer of other female genital organs
pelvic exenteration	reserved for	unresectable cancer of other female genital organs
external beam radiotherapy	used for	local control of cancer of other female genital organs
brachytherapy	used for	vaginal cancer
cisplatin	used with	radiotherapy for cancer of other female genital organs
carboplatin	used with	radiotherapy for cancer of other female genital organs
paclitaxel	used with	carboplatin for cancer of other female genital organs
bevacizumab	explored for	cancer of other female genital organs
immunotherapy	explored for	cancer of other female genital organs
neoadjuvant therapy	used for	cancer of other female genital organs
adjuvant therapy	used for	cancer of other female genital organs
postoperative radiotherapy	used for	cancer of other female genital organs
neoadjuvant chemoradiation	used for	cancer of other female genital organs
systemic chemotherapy	used for	cancer of other female genital organs
palliative radiotherapy	used for	cancer of other female genital organs
life expectancy	depends on	cancer of other female genital organs
overall survival	depends on	stage at diagnosis
disease-free survival	improves with	complete resection
disease-free survival	improves with	adjuvant therapy
positive margins	associated with	local recurrence in cancer of other female genital organs
negative margins	associated with	reduced recurrence in cancer of other female genital organs
lymph node status	predicts	survival in cancer of other female genital organs
distant metastasis	indicates	stage IV cancer of other female genital organs
tumor size	correlates with	prognosis in cancer of other female genital organs
tumor grade	correlates with	prognosis in cancer of other female genital organs
histology	determines	histologic type in cancer of other female genital organs
squamous cell carcinoma	is histology type in	cancer of other female genital organs
adenocarcinoma	is histology type in	cancer of other female genital organs
melanoma	is histology type in	cancer of other female genital organs
HPV infection	associated with	vaginal cancer
smoking	associated with	vulvar cancer
immunosuppression	associated with	cancer of other female genital organs
diabetes mellitus	associated with	mortality in cancer of other female genital organs
obesity	associated with	poor outcome in cancer of other female genital organs
anemia	associated with	poor prognosis in cancer of other female genital organs
neutropenia	associated with	chemotherapy for cancer of other female genital organs
neoadjuvant therapy	improves	surgical outcomes in cancer of other female genital organs
adjuvant therapy	improves	disease-free survival in cancer of other female genital organs
postoperative radiotherapy	reduces	local recurrence in cancer of other female genital organs
chemoradiation	improves	local control in cancer of other female genital organs
radiation therapy	provides	symptom relief in cancer of other female genital organs
systemic therapy	provides	systemic disease control in cancer of other female genital organs
palliative care	supports	patient quality of life in cancer of other female genital organs
clinical trial	offers	new therapy options for cancer of other female genital organs
randomized trial	evaluates	therapy for cancer of other female genital organs
targeted therapy	evaluated for	cancer of other female genital organs
tumor mutational burden	predicts	response to immunotherapy in cancer of other female genital organs
MSI status	predicts	response to immunotherapy in cancer of other female genital organs
BRCA mutation	rare in	cancer of other female genital organs
PD-L1 expression	associated with	immunotherapy response in cancer of other female genital organs
tumor size	measured by	imaging for cancer of other female genital organs
cellular density	estimated by	biopsy for cancer of other female genital organs
imaging	guides	treatment planning for cancer of other female genital organs
multidisciplinary team	coordinates	treatment for cancer of other female genital organs
tumor board	reviews	cancer of other female genital organs
local disease control	achieved by	radiotherapy for cancer of other female genital organs
local disease control	achieved by	surgery for cancer of other female genital organs
systemic disease control	achieved by	chemotherapy for cancer of other female genital organs
terminal stage	defined as	stage IV cancer of other female genital organs
ambulatory care	suitable for	follow-up of cancer of other female genital organs
follow-up visit	scheduled for	cancer of other female genital organs
survivor	lives with	cancer of other female genital organs
care plan	tailored for	cancer of other female genital organs
healthcare utilization	increased by	cancer of other female genital organs
readmission	risk in	cancer of other female genital organs
hospitalization	risk in	cancer of other female genital organs
emergency admission	associated with	cancer of other female genital organs
pain	symptom in	cancer of other female genital organs
bleeding	symptom in	cancer of other female genital organs
abdominal pain	symptom in	cancer of other female genital organs
pelvic pain	symptom in	cancer of other female genital organs
weight loss	symptom in	cancer of other female genital organs
cachexia	associated with	cancer of other female genital organs
performance status	predicts	mortality in cancer of other female genital organs
electrolyte imbalance	complication in	cancer of other female genital organs
nutritional deficiency	complication in	cancer of other female genital organs
